Fri, Jun 27, 8:02 PM (17 days ago)
**Aixin Life International, Inc. (AIXN) - Q1 2025 Summary** **Financial Health & Performance:** - **Revenue:** $398,831 (down 53% YoY from $851,559 in Q1 2024). - **Profit Margins:** Negative, with a net loss of $721,708 (up 20% YoY from $603,600 in Q1 2024). - **Cash Flow:** Negative operating cash flow of $675,948, but positive net cash flow from financing activities of $676,398. - **Liquidity:** Working capital deficit of $6,708,468 as of March 31, 2025. **Segment Performance:** - **Direct Sales:** Revenue down 88% to $20,631. - **Pharmacy:** Revenue down 85% to $35,966. - **Hotel:** Revenue down 48% to $80,706. - **Manufacture & Sale:** Revenue down 10% to $261,528. **Trends & Uncertainties:** - Decreased sales due to economic downturn and reduced marketing activities. - Increased losses in pharmacy and manufacture & sale segments. - Going concern uncertainties due to negative cash flow and working capital deficit. **Future Operations Impact:** - Plans to improve liquidity through cost reductions, higher-margin product sales, and potential equity offerings. - Risks include market competition, economic conditions, and regulatory changes. **Management Discussion:** - Acknowledges challenges and uncertainties but expresses confidence in the liquidity plan. - Focuses on cost control, product innovation, and exploring new business opportunities. **Note:** All amounts are in thousands.